Preventing Dyspnea During Speech in Older Speakers

NCT ID: NCT05029986

Last Updated: 2022-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-15

Study Completion Date

2022-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Due to various comorbidities affecting the respiratory system, older speakers are at risk of experiencing breathing discomfort (dyspnea) during high-demand vocal activities such as singing, loud speaking, and speaking while exercising. Dyspnea during speech can promote avoidance of certain situations involving voice production, thus leading to vocal deconditioning and decreased quality of life. The goal of this pilot study is to test the feasibility and acceptability of a 4-week remote group intervention targeting phonatory dyspnea, and to gather preliminary efficacy data.

Participants will receive an intervention including a 2-week socialization phase (control condition) and a 4-week speech breathing intervention phase (experimental condition). Both phases will be delivered remotely and in a group setting (10 participants per group).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyspnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All participants

This is a single-arm trial. All participants will receive (1) a control condition (socialization phase, 2 weeks) and (2) an intervention condition (speech breathing intervention, 4 weeks). Group sessions will take place once a week, and participants will be instructed to practice their exercises every day at home during the study duration.

Group Type EXPERIMENTAL

Socialization phase

Intervention Type BEHAVIORAL

Control condition: does not involve speech-related exercises

Speech breathing intervention

Intervention Type BEHAVIORAL

Experimental condition: involves speech-related exercises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Socialization phase

Control condition: does not involve speech-related exercises

Intervention Type BEHAVIORAL

Speech breathing intervention

Experimental condition: involves speech-related exercises

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* sign the informed consent form
* report dyspnea in at least one of the items of the University of Cincinnati Dyspnea Questionnaire referring to speech
* be available during the dates of the scheduled group interventions
* be aged 50 years or older

Exclusion Criteria

* do not have access to a computer and internet connection
* present with a known voice pathology (other than age-related vocal fold atrophy) and/or are receiving speech therapy at the time of the study
* have a known neurodegenerative disease affecting speech/voice
* are a current smoker
* are receiving pulmonary rehabilitation at the time of the study or are starting a new medication regimen for a respiratory disease at the time of study onset;
* have a hearing loss that is not adequately managed, as judged by the Principal Investigator (PI)
* have professional vocal training \[amateur choir singers will not be excluded\]
* cannot provide informed consent or easily follow instructions
* have any other condition that precludes them from participating in the behavioral interventions, as judged by the PI.
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Delaware

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maude Desjardins

Post-doctoral researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Delaware

Newark, Delaware, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1767412

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lifestyle Intervention in Obstructive Sleep Apnoea
NCT01546792 COMPLETED PHASE2/PHASE3
Low-Tech Treatments for Obstructive Sleep Apnea
NCT07301710 NOT_YET_RECRUITING PHASE1/PHASE2